什么是乙类药品？

中文版

乙类药品是指由国家医疗保障局制定并公布的基本医疗保险药品目录中的药品，属于医保支付范围内的药品。乙类药品目录内的药品在疗效、安全性、质量等方面经过国家医疗保障局的评估，被认定为符合基本医疗保险用药要求的药品。

乙类药品目录通常包括西药、中药、生物制品等多个类别，其中涉及的治疗领域非常广泛，包括抗肿瘤、抗病毒、心血管、神经系统、免疫调节等多个方面。这些药品在医保支付范围内的报销比例由国家医疗保障局制定，不同地区和不同医保政策下的报销比例可能有所不同。

乙类药品的纳入，旨在保障参保人员的用药需求，减轻患者的经济负担，提高医疗保障水平。同时，乙类药品目录的更新和调整也是根据临床需求、药品疗效、安全性等因素进行的，以保证医保药品目录的科学性和合理性。

英文版

What Are Class B Drugs?

Class B drugs refer to the drugs listed in the basic medical insurance drug catalog published by the National Medical Security Administration, which fall within the scope of medical insurance payment. Drugs included in the Class B drug catalog have undergone evaluation by the National Medical Security Administration in terms of efficacy, safety, quality, and other aspects, and are recognized as drugs that meet the requirements for basic medical insurance medication use.

The Class B drug catalog typically includes multiple categories such as western medicine, traditional Chinese medicine, and biological products, covering a wide range of treatment areas including anti-tumor, anti-viral, cardiovascular, nervous system, immune regulation, and more. The reimbursement rates for these drugs within the scope of medical insurance payment are formulated by the National Medical Security Administration, and may vary in different regions and under different medical insurance policies.

The inclusion of Class B drugs aims to safeguard the medication needs of insured individuals, reduce the economic burden on patients, and improve the level of medical security. At the same time, the updating and adjustment of the Class B drug catalog are also carried out based on clinical needs, drug efficacy, safety, and other factors to ensure the scientificity and rationality of the medical insurance drug catalog.